Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Cost of Revenue (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed Cost of Revenue for 6 consecutive years, with $881.7 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cost of Revenue rose 45.67% year-over-year to $881.7 million, compared with a TTM value of $2.9 billion through Jun 2025, up 60.02%, and an annual FY2024 reading of $2.4 billion, up 48.33% over the prior year.
  • Cost of Revenue was $881.7 million for Q2 2025 at Alignment Healthcare, up from $820.9 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $881.7 million in Q2 2025 and bottomed at $251.1 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $438.1 million, with a median of $396.3 million recorded in 2023.
  • The sharpest move saw Cost of Revenue increased 11.98% in 2022, then surged 54.18% in 2024.
  • Year by year, Cost of Revenue stood at $259.6 million in 2021, then increased by 25.59% to $326.0 million in 2022, then increased by 28.15% to $417.8 million in 2023, then skyrocketed by 47.19% to $614.9 million in 2024, then soared by 43.4% to $881.7 million in 2025.
  • Business Quant data shows Cost of Revenue for ALHC at $881.7 million in Q2 2025, $820.9 million in Q1 2025, and $614.9 million in Q4 2024.